Trial site
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
- 23running trials
- 10closed trials
The trials here
What the 33 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer14 trials
- Lung cancer10 trials
- Pancreatic cancer5 trials
- Ovarian cancer4 trials
- Colorectal cancer3 trials
- Head and neck cancer3 trials
- Kidney cancer3 trials
- Endometrial cancer2 trials
- Melanoma2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- and 7 more
- Phase
- Phase 214 trials
- Phase 16 trials
- Phase 1/23 trials
- Phase 33 trials
- Status
- Recruiting15 trials
- Active, not recruiting8 trials
- Completed7 trials
- Terminated2 trials
- Withdrawn1 trial
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins12 trials
- H. Lee Moffitt Cancer Center and Research Institute3 trials
- Prostate Cancer Clinical Trials Consortium2 trials
- BioNTech SE1 trial
- Clasp Therapeutics, Inc.1 trial
- and 14 more
Running trials
Recruiting
Recruiting
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Recruiting
Recruiting
Recruiting
Recruiting
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Recruiting
Recruiting
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
Recruiting
Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Recruiting
Active, not recruiting
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
Recruiting
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion
Recruiting
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
Recruiting
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Active, not recruiting
Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer7 recruiting
- Lung cancer4 recruiting
- Colorectal cancer2 recruiting
- Head and neck cancer2 recruiting
- Kidney cancer2 recruiting
- Ovarian cancer2 recruiting
- Pancreatic cancer2 recruiting
- Bladder cancer1 recruiting
- Childhood cancers1 recruiting
- Endometrial cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Withdrawn
Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer
Terminated
Terminated
Completed
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
Completed
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
Completed
Completed
Pancreatic Adenocarcinoma Signature Stratification for Treatment
Completed
Completed
A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026